Illinois Disputes Generic Drugmakers’ Bid for Pricing Law Pause

Illinois’ interest in making generic drugs more affordable outweighs harms manufacturers may suffer under the state’s anti-price gouging law, the state attorney general argued Friday in response to an industry group’s request for a court-ordered enforcement pause.

The generic drug and biosimilar industry group failed to establish that the financial penalties its members could face under the Illinois law prohibiting excessive price gouging on generic and other off-patent drugs outweighs the state’s interest in “preventing activity that will directly impact the health of its residents,” Illinois Attorney General Kwame Raoul (D) wrote in his brief filed in the US District ...